Polymorphonuclear leukocyte degranulation induced by leukotoxin from Actinobacillus actinomycetemcomitans

Area of Science:

• Immunology
• Cell Biology
• Microbiology

Background:

• Actinobacillus actinomycetemcomitans produces leukotoxin, a virulence factor.
• Human polymorphonuclear leukocytes (PMNL) are key immune cells involved in host defense.
• Lysosomal release is crucial for PMNL function but can be dysregulated.

Purpose of the Study:

• To investigate the effect of A. actinomycetemcomitans leukotoxin on lysosomal constituent release from human PMNL.
• To elucidate the mechanism and kinetics of leukotoxin-induced lysosomal exocytosis.

Main Methods:

• Incubation of human PMNL with purified leukotoxin or leukotoxic bacteria.
• Analysis of PMNL morphology using electron microscopy.
• Quantification of extracellular lactoferrin, elastase, and lactate dehydrogenase using ELISA.
• Detection of surface markers CD63 and CD66b.
• Inhibition studies using anti-leukotoxin serum and anti-integrin antibodies.

Main Results:

• Leukotoxin exposure rapidly reduced intracellular granules and translocated them to the periphery in PMNL.
• Extracellular lactoferrin and elastase levels increased, while lactate dehydrogenase remained low, indicating granule release without significant lysis.
• Surface exposure of CD63 and CD66b indicated lysosome-plasma membrane fusion.
• Effects were abolished by anti-leukotoxin serum; anti-integrin antibodies inhibited cytolysis but not granule release.

Conclusions:

• A. actinomycetemcomitans leukotoxin actively triggers rapid release of lysosomal compounds from human PMNL.
• The process involves granule exocytosis and membrane fusion, stimulated by PMNL-toxin interaction.
• Leukotoxin's mechanism of action on PMNL involves distinct pathways for granule release and cell lysis.